Lipidated oxoadenine derivatives

Details for Australian Patent Application No. 2010279299 (hide)

Owner GlaxoSmithKline Biologicals sa

Inventors Johnson, David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010279299

PCT Pub. Number WO2011/017611

Priority 61/232,132 07.08.09 US

Filing date 6 August 2010

Wipo publication date 10 February 2011

International Classifications

A01N 43/90 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds - having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

A61K 31/52 (2006.01)

A61K 31/522 (2006.01)

Event Publications

29 March 2012 PCT application entered the National Phase

  PCT publication WO2011/017611 Priority application(s): WO2011/017611

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010279302-Methods and compositions for diagnosis and prognosis of renal injury and renal failure

2010279295-Highly wear resistant diamond insert with improved transition structure